Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy
Clinical trial NCT05672979 · UNKNOWN
Trial details
- NCT number
- NCT05672979
- Sponsor
- Yeungnam University College of Medicine
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.